Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1-Reference-Cited by-同舟云学术

Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1

Published:2022-06-15 Issue:6 Volume:30 Page:553-561
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomol Ther (Seoul)

Author:

Gao Shan¹,Guo Tingting¹,Luo Shuyu¹²,Zhang Yan¹,Ren Zehao¹,Lang Xiaona¹,Hu Gaoyong³,Zuo Duo⁴,Jia Wenqing¹,Kong Dexin¹,Yu Haiyang³,Qiu Yuling¹

Affiliation:

1. Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China

2. School and Hospital of Stomatology, Tianjin Medical University, Tianjin 300070, China

3. State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China

4. Department of Clinical Laboratory, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2022/030/BT030-06-553.pdf

Reference32 articles.

1. A Review on the Therapeutic Role of TKIs in Case of CML in Combination With Epigenetic Drugs

2. An update on the biology of sphingosine 1-phosphate receptors